Bio-Thera Strengthens Ties With Pharmapark By Adding Ustekinumab

Follows Earlier License And Supply Agreement For Golimumab Biosimilar

 
• By Dean Rudge
  
Russia
Bio-Thera has signed another deal for its Stelara biosimilar • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products